Torreya Insights

Torreya was a premier global investment banking and strategic advisory firm dedicated exclusively to the life sciences industry. The firm provided a wide range of services, including mergers and acquisitions advisory, capital markets solutions, and strategic licensing for biotechnology and pharmaceutical companies. Torreya was highly regarded for its data-driven approach and deep industry expertise, frequently publishing influential research reports under the 'Torreya Insights' brand, such as the 'Torreya 600.' Its global footprint included offices in major financial hubs like New York, London, and Mumbai, allowing it to facilitate complex cross-border transactions. In February 2023, Torreya was acquired by Stifel Financial Corp., where its team and specialized capabilities were integrated into Stifel's healthcare investment banking division.